The Nordic Life Science Review 2010 Q1 includes four pages about the Encubator portfolio company from GIBBS, Arterion as well as a short piece about the Encubator portfolio company from CSE, Denator, signing distribution agreements with Bucher Biotec AG for the Swiss market.
The four-page spread about Arterion explains how the school, Göteborg International Bioscience Business School has been an invaluable support to the project and the entrepreneurs involved in the project. The article also explains, in short, the technology behind the company and how they won the MedTech Investment Day Award 2010. Arterion's CEO, Karl-Richard Nilsson, speaks out about how to run a company and challenges for the future.
Read about Denator on page 9 and Arterion on pages 12-15 in the attached PDF below.
Arterion develops biomaterials based on microbially derived cellulose.
Tags
Published
Tuesday, April 20, 2010 - 10:09
